See other companies on Welcome to the Jungle
Proscia
Pathology solutions
- 21-100 employees
- Healthcare
- B2B
- Artificial Intelligence
- SaaS
- MedTech
- Center City West, Philadelphia, PA
Jump to section
Company mission
To perfect cancer diagnosis with intelligent software that changes the way the world practices pathology.
-13% employee growth in 12 months
Our take
Data suggests that whilst the number of people with cancer is expected to rise by 47% by 2040, the number of pathologists in the United States will decline by 17.53%. For this reason, there is a need to digitalise pathology. Proscia uses computing, visualisation and machine learning to aid pathologists towards diagnosing cancers.
Proscia is very well positioned in the explosive medicine market with its services currently being used by 10 of the top 20 pharmaceutical companies. The company has successfully developed algorithms using commercially available technology that reaches ‘substantial agreement’ with the human read, thereby cementing itself as a rare and much needed solution to the declining access to human pathologists.
Previous funding rounds saw Proscia launch new products, such as an automated quality control application that improves the efficiency of data-driven drug development. 2022 capital is broadening Proscia's portfolio of computational solutions, which in turn should strengthen its market and product leadership.
Steph
Company Specialist at Welcome to the Jungle
Benefits
- Medical, dental, vision insurance
- Unlimited PTO
- Retirement plan options
- Commuter benefits
- Company sponsored short- and long-term disability plans
Company values
- Disrespect the Status Quo
- Come Hungry
- Raise the Bar
- Win as a Team
- Do Good
Funding (last 2 of 6 rounds)
Mar 2024
$9m
SERIES C
Jun 2022
$37m
SERIES C
Total funding: $79.3m
This company has top investors
Leadership
Coleman Stavish
(CTO)Previously worked as an Independent iOS Developer before joining Bombardier Transportation as a Software Engineering Co-op.
David West
(CEO)Prior to founding Proscia, received a Bachelor of Science in Bioengineering and Biomedical Engineering from The Johns Hopkins University.
Nathan Buchbinder
(CPO)Before acting as CPO, served as Vice President of Operations. Previously co-invented Design Team: The Cooling Cure and has been a Team Leader for Biliary and Pulmonary Brush Biopsy and Sleep Apnea Monitor Development.
Articles
Jobs (2)
Software Engineering